Vav-family proteins in T-cell signalling

Current Opinion in Immunology

Volumn 17, Issue 3, 2005, Pages 267-274

  Tybulewicz, Victor L J ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ARGININE; CALCIUM ION; CHEMOKINE; DYNAMIN II; EZRIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MITOGEN ACTIVATED PROTEIN KINASE; MOESIN; NUCLEAR PROTEIN; RADIXIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TYROSINE; VAV PROTEIN; WISKOTT ALDRICH SYNDROME PROTEIN;

CALCIUM TRANSPORT; CELL NUCLEUS; CELL POLARITY; CYTOPLASM; ENZYME ACTIVATION; HUMAN; IMMUNOBIOLOGY; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE STRAIN; NONHUMAN; POLARIZATION; PROTEIN DEFICIENCY; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CELL CYCLE PROTEINS; GENE EXPRESSION REGULATION; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MICE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-VAV; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 18844449626     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2005.04.003     Document Type: Review

References (73)

1. S. Katzav, D. Martin-Zanca, and M. Barbacid Vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells EMBO J 8 1989 2283 2290
2. E.P. Henske, M.P. Short, S. Jozwiak, C.M. Bovey, S. Ramlakhan, J.L. Haines, and D.J. Kwiatkowski Identification of VAV2 on 9q34 and its exclusion as the tuberous sclerosis gene TSC1 Ann Hum Genet 59 1995 25 37
3. K.E. Schuebel, X.R. Bustelo, D.A. Nielsen, B.J. Song, M. Barbacid, D. Goldman, and I.J. Lee Isolation and characterization of murine vav2, a member of the vav family of proto-oncogenes Oncogene 13 1996 363 371
4. N. Movilla, and X.R. Bustelo Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins Mol Cell Biol 19 1999 7870 7885
5. X.R. Bustelo, J.A. Ledbetter, and M. Barbacid Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates Nature 356 1992 68 71
6. B. Margolis, P. Hu, S. Katzav, W. Li, J.M. Oliver, A. Ullrich, A. Weiss, and J. Schlessinger Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs Nature 356 1992 71 74
7. S.L. Moores, L.M. Selfors, J. Fredericks, T. Breit, K. Fujikawa, F.W. Alt, J.S. Brugge, and W. Swat Vav family proteins couple to diverse cell surface receptors Mol Cell Biol 20 2000 6364 6373
8. D.D. Billadeau, S.M. Mackie, R.A. Schoon, and P.J. Leibson The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity J Exp Med 192 2000 381 392
9. S. Tartare-Deckert, M.N. Monthouel, C. Charvet, I. Foucault, E. Van Obberghen, A. Bernard, A. Altman, and M. Deckert Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte J Biol Chem 276 2001 20849 20857
10. G.M. Doody, S.E. Bell, E. Vigorito, E. Clayton, S. McAdam, R. Tooze, C. Fernandez, I.J. Lee, and M. Turner Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation Nat Immunol 2 2001 542 547
11. K. Fujikawa, A.V. Miletic, F.W. Alt, R. Faccio, T. Brown, J. Hoog, J. Fredericks, S. Nishi, S. Mildiner, and S.L. Moores Vav1/2/3-null Mice Define an Essential Role for Vav Family Proteins in Lymphocyte Development and Activation but a Differential Requirement in MAPK Signalling in T and B Cells J Exp Med 198 2003 1595 1608 This paper reports the generation of mice deficient in all three Vav proteins - Vav1, Vav2 and Vav3 - and shows functional redundancy between them for T-cell development and activation.
12. X.R. Bustelo Regulatory and signalling properties of the Vav family Mol Cell Biol 20 2000 1461 1477
13. X.R. Bustelo Vav proteins, adaptors and cell signalling Oncogene 20 2001 6372 6381
14. M. Turner, and D.D. Billadeau VAV proteins as signal integrators for multi-subunit immune-recognition receptors Nat Rev Immunol 2 2002 476 486
15. S. Katzav Vav1: an oncogene that regulates specific transcriptional activation of T cells Blood 103 2004 2443 2451
16. J.M. Adams, H. Houston, J. Allen, T. Lints, and R. Harvey The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization Oncogene 7 1992 611 618
17. Y. Zheng Dbl family guanine nucleotide exchange factors Trends Biochem Sci 26 2001 724 732
18. P. Crespo, K.E. Schuebel, A.A. Ostrom, J.S. Gutkind, and X.R. Bustelo Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product Nature 385 1997 169 172
19. K.E. Schuebel, N. Movilla, J.L. Rosa, and X.R. Bustelo Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2 EMBO J 17 1998 6608 6621
20. J. Han, B. Das, W. Wei, L. Van Aelst, R.D. Mosteller, R. Khosravi-Far, J.K. Westwick, C.J. Der, and D. Broek Lck regulates Vav activation of members of the Rho family of GTPases Mol Cell Biol 17 1997 1346 1353
21. K. Abe, K.L. Rossman, B. Liu, K.D. Ritola, D. Chiang, S.L. Campbell, K. Burridge, and C.J. Der Vav2 is an activator of Cdc42, Rac1, and RhoA J Biol Chem 275 2000 10141 10149
22. M. Lopez-Lago, H. Lee, C. Cruz, N. Movilla, and X.R. Bustelo Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav Mol Cell Biol 20 2000 1678 1691
23. B. Aghazadeh, W.E. Lowry, X.Y. Huang, and M.K. Rosen Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation Cell 102 2000 625 633
24. J.L. Zugaza, M.A. Lopez-Lago, M.J. Caloca, M. Dosil, N. Movilla, and X.R. Bustelo Structural determinants for the biological activity of Vav proteins J Biol Chem 277 2002 45377 45392
25. N. Yabana, and M. Shibuya Adaptor protein APS binds the NH2-terminal autoinhibitory domain of guanine nucleotide exchange factor Vav3 and augments its activity Oncogene 21 2002 7720 7729
26. J. Han, K. Luby-Phelps, B. Das, X. Shu, Y. Xia, R.D. Mosteller, U.M. Krishna, J.R. Falck, M.A. White, and D. Broek Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav Science 279 1998 558 560
27. B. Das, X. Shu, G.J. Day, J. Han, U.M. Krishna, J.R. Falck, and D. Broek Control of intramolecular interactions between the pleckstrin homology and Dbl homology domains of Vav and Sos1 regulates Rac binding J Biol Chem 275 2000 15074 15081
28. A. Tarakhovsky, M. Turner, S. Schaal, P.J. Mee, L.P. Duddy, K. Rajewsky, and V.L.J. Tybulewicz Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav Nature 374 1995 467 470
29. R. Zhang, F.W. Alt, L. Davidson, S.H. Orkin, and W. Swat Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene Nature 374 1995 470 473
30. K.D. Fischer, A. Zmuidzinas, S. Gardner, M. Barbacid, A. Bernstein, and C. Guidos Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes Nature 374 1995 474 477
31. M. Turner, P.J. Mee, A. Walters, M.E. Quinn, A.L. Mellor, R. Zamoyska, and V.L.J. Tybulewicz A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes Immunity 7 1997 451 460
32. Y.Y. Kong, K.D. Fischer, M.F. Bachmann, S. Mariathasan, I. Kozieradzki, M.P. Nghiem, D. Bouchard, A. Bernstein, P.S. Ohashi, and J.M. Penninger Vav regulates peptide-specific apoptosis in thymocytes J Exp Med 188 1998 2099 2111
33. W. Swat, R. Xavier, A. Mizoguchi, E. Mizoguchi, J. Fredericks, K. Fujikawa, A.K. Bhan, and F.W. Alt Essential role for Vav1 in activation, but not development, of γδ T cells Int Immunol 15 2003 215 221 This paper shows a role for Vav 1 in the activation, but not development, of γδ T cells.
34. K. Tedford, L. Nitschke, I. Girkontaite, A. Charlesworth, G. Chan, V. Sakk, M. Barbacid, and K.D. Fischer Compensation between Vav-1 and Vav-2 in B cell development and antigen receptor signalling Nat Immunol 2 2001 548 555
35. K.-D. Fischer, Y.-Y. Kong, H. Nishina, K. Tedford, L.E.M. Marengère, I. Kozieradzki, T. Sasaki, M. Starr, G. Chan, and S. Gardener Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor Curr Biol 8 1998 554 562
36. J.M. Penninger, K.D. Fischer, T. Sasaki, I. Kozieradzki, J. Le, K. Tedford, K. Bachmaier, P.S. Ohashi, and M.F. Bachmann The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulation Eur J Immunol 29 1999 1709 1718
37. A. Gulbranson-Judge, V.L. Tybulewicz, A.E. Walters, K.M. Toellner, I.C. MacLennan, and M. Turner Defective immunoglobulin class switching in Vav-deficient mice is attributable to compromised T cell help Eur J Immunol 29 1999 477 487
38. P.S. Costello, A.E. Walters, P.J. Mee, M. Turner, L.F. Reynolds, A. Prisco, N. Sarner, R. Zamoyska, and V.L.J. Tybulewicz The Rho-family GTP exchange factor Vav is a critical transducer of TCR signals to the calcium, ERK and NF-κB pathways Proc Natl Acad Sci USA 96 1999 3035 3040
39. L.J. Holsinger, I. Graef, W. Swat, T. Chi, D.M. Bautista, L. Davidson, R.S. Lewis, F.W. Alt, and G.R. Crabtree Defects in actin cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction Curr Biol 8 1998 563 572
40. L.F. Reynolds, L.A. Smyth, T. Norton, N. Freshney, J. Downward, D. Kioussis, and V.L.J. Tybulewicz Vav1 transduces T cell receptor signals to the activation of phospholipase C-γ1 via phosphoinositide 3-kinase-dependent and -independent pathways J Exp Med 195 2002 1103 1114
41. C.M. Lewis, C. Broussard, M.J. Czar, and P.L. Schwartzberg Tec kinases: modulators of lymphocyte signalling and development Curr Opin Immunol 13 2001 317 325
42. •].
43. K.F. Tolias, L.C. Cantley, and C.L. Carpenter Rho family GTPases bind to phosphoinositide kinases J Biol Chem 270 1995 17656 17659
44. Y. Zheng, S. Bagrodia, and R.A. Cerione Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85 J Biol Chem 269 1994 18727 18730
45. G.M. Bokoch, C.J. Vlahos, Y. Wang, U.G. Knaus, and A.E. Traynor-Kaplan Rac GTPase interacts specifically with phosphatidylinositol 3-kinase Biochem J 315 1996 775 779
46. C.M. Labno, C.M. Lewis, D. You, D.W. Leung, A. Takesono, N. Kamberos, A. Seth, L.D. Finkelstein, M.K. Rosen, and P.L. Schwartzberg Itk functions to control actin polymerization at the immune synapse through localized activation of Cdc42 and WASP Curr Biol 13 2003 1619 1624 This paper shows that Itk is required for the recruitment of Vav1 to the immunological synapse.
47. •].
48. Y. Cao, E.M. Janssen, A.W. Duncan, A. Altman, D.D. Billadeau, and R.T. Abraham Pleiotropic defects in TCR signalling in a Vav-1-null Jurkat T-cell line EMBO J 21 2002 4809 4819
49. S. Zakaria, T.S. Gomez, D.N. Savoy, S. McAdam, M. Turner, R.T. Abraham, and D.D. Billadeau Differential regulation of TCR-mediated gene transcription by Vav family members J Exp Med 199 2004 429 434 RNAi-mediated knockdown of Vav1 and Vav3 in Jurkat T cells shows distinct functions for the two proteins.
50. B domain of Vav1, and, using RNAi, shows that dynamin2 is critical for TCR signal transduction.
51. S. Etienne-Manneville, and A. Hall Rho GTPases in cell biology Nature 420 2002 629 635
52. K.D. Fischer, K. Tedford, and J.M. Penninger Vav links antigen-receptor signalling to the actin cytoskeleton Semin Immunol 10 1998 317 327
53. M.L. Dustin, S.K. Bromley, Z. Kan, D.A. Peterson, and E.R. Unanue Antigen receptor engagement delivers a stop signal to migrating T lymphocytes Proc Natl Acad Sci USA 94 1997 3909 3913
54. Monks CRF, B.A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer Three-dimensional segregation of supramolecular activation clusters in T cells Nature 395 1998 82 86
55. A. Kupfer, and S.J. Singer The specific interaction of helper T cells and antigen-presenting B cells. IV. Membrane and cytoskeletal reorganizations in the bound T cell as a function of antigen dose J Exp Med 170 1989 1697 1713
56. C. Krawczyk, A. Oliveira-dos-Santos, T. Sasaki, E. Griffiths, P.S. Ohashi, S. Snapper, F. Alt, and J.M. Penninger Vav1 controls integrin clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells Immunity 16 2002 331 343
57. L. Ardouin, M. Bracke, A. Mathiot, S.N. Pagakis, T. Norton, N. Hogg, and V.L.J. Tybulewicz Vav1 transduces TCR signals required for LFA-1 function and cell polarization at the immunological synapse Eur J Immunol 33 2003 790 797 Vav1 transduces an inside-out signal from the TCR to LFA-1, and is required for cell polarisation. See also [56].
58. C. Wülfing, A. Bauch, G.R. Crabtree, and M.M. Davis The vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte-antigen-presenting cell interface Proc Natl Acad Sci USA 97 2000 10150 10155
59. M. Villalba, K. Bi, F. Rodriguez, Y. Tanaka, S. Schoenberger, and A. Altman Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells J Cell Biol 155 2001 331 338
60. M.P. Stewart, A. McDowall, and N. Hogg LFA-1-mediated adhesion is regulated by cytoskeletal restraint and by a Ca2+-dependent protease, calpain J Cell Biol 140 1998 699 707
61. R. Zeng, J.L. Cannon, R.T. Abraham, M. Way, D.D. Billadeau, J. Bubeck-Wardenberg, and J.K. Burkhardt SLP-76 coordinates Nck-dependent Wiskott-Aldrich syndrome protein recruitment with Vav-1/Cdc42-dependent Wiskott-Aldrich syndrome protein activation at the T cell-APC contact site J Immunol 171 2003 1360 1368 This paper shows that WASP is recruited to the adaptor SLP-76 via Nck where it is co-localised with Vav1 and activated by Cdc42.
62. J. Delon, K. Kaibuchi, and R.N. Germain Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin Immunity 15 2001 691 701
63. S. Faure, L.I. Salazar-Fontana, M. Semichon, V.L. Tybulewicz, G. Bismuth, A. Trautmann, R.N. Germain, and J. Delon ERM proteins regulate cytoskeleton relaxation promoting T cell-APC conjugation Nat Immunol 5 2004 272 279 TCR-induced dephosphorylation of ERM proteins is mediated by Vav1 and Rac1.
64. M. Houlard, R. Arudchandran, F. Regnier-Ricard, A. Germani, S. Gisselbrecht, U. Blank, J. Rivera, and N. Varin-Blank Vav1 is a component of transcriptionally active complexes J Exp Med 195 2002 1115 1127
65. C.T. Baldari, G. Koretzky, J.L. Telford, and O. Acuto Antigen receptor signalling: the Tuscan chronicles Nat Immunol 6 2005 3 5
66. M.A. del Pozo, M.A. Schwartz, J. Hu, W.B. Kiosses, A. Altman, and M. Villalba Guanine exchange-dependent and -independent effects of Vav1 on integrin-induced T cell spreading J Immunol 170 2003 41 47
67. Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W: Vav3 regulates osteoclast function and bone mass. Nat Med 2005, 11 in press.
68. M.A. Gakidis, X. Cullere, T. Olson, J.L. Wilsbacher, B. Zhang, S.L. Moores, K. Ley, W. Swat, T. Mayadas, and J.S. Brugge Vav GEFs are required for beta2 integrin-dependent functions of neutrophils J Cell Biol 166 2004 273 282
69. M. Vicente-Manzanares, A. Cruz-Adalia, N.B. Martin-Cofreces, J.R. Cabrero, M. Dosil, B. Alvarado-Sanchez, X.R. Bustelo, and F. Sanchez-Madrid Control of lymphocyte shape and the chemotactic response by the GTP exchange factor Vav Blood 105 2005 3026 3034 Overexpression of a mutant form of Vav1 blocks SDF-1α-induced chemotaxis, although no defect is seen in Vav1-deficient T cells.
70. V. Tybulewicz, L. Ardouin, A. Prisco, and L.F. Reynolds Vav1: a key signal transducer downstream of the TCR Immunol Rev 192 2003 42 52
71. M. Houlard, F. Romero-Portillo, A. Germani, A. Depaux, F. Regnier-Ricard, S. Gisselbrecht, and N. Varin-Blank Characterization of VIK-1: a new Vav-interacting Kruppel-like protein Oncogene 24 2005 28 38
72. S.L. Miller, J.E. Demaria, D.O. Freier, A.M. Riegel, and C.V. Clevenger Novel association of Vav2 and Nek3 modulates signalling through the human prolactin receptor Mol Endocrinol 2004
73. Llorca O, Arias-Palomo E, Zugaza JL, Bustelo XR: Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3. EMBO J 2005, DOI: 10.1038/sj.emboj.7600617 (Published online March 10 2005). This paper reports the electron microscopic analysis of Vav3, supporting the model that the CH domain binds the C1 domain, thereby holding the protein in a closed auto-inhibited state. See also [24]